使用多州模型预测库尔德斯坦省住院患者的COVID-19进展情况
Shnoo Bayazidi1,2, Ghobad Moradi3, Safdar Masoumi4,5
1Department of Epidemiology, School of Public Health, Iran University of Medical Sciences, Tehran, Iran.
Journal of diabetes and metabolic disorders
|March 25, 2025
概括
一个多州模型预测了住院患者的COVID-19进展情况. 关键因素包括年龄,糖尿病和心血管疾病,为临床决策和资源分配提供信息.
科学领域:
- 流行病学 流行病学
- 生物统计学 生物统计学
- 医疗保健服务研究 医疗服务研究
背景情况:
- 在全球范围内,COVID-19给医疗保健系统带来了重大挑战.
- 准确预测疾病进展对于有效的患者管理和资源分配至关重要.
- 住院患者表现出不同的临床轨迹,需要复杂的预测模型.
研究的目的:
- 在住院患者中实施和评估COVID-19进展的多州风险预测模型.
- 确定影响COVID-19患者结果的关键临床和社会人口因素.
- 为患者护理和医疗保健资源管理提供知情决策工具.
主要方法:
- 在库尔德斯坦省 (2019年3月 - 2021年12月) 住院的17286名COVID-19患者的回顾性分析.
- 应用多状态预测模型来分析健康状态之间的过渡 (例如,恢复,重症监护,死亡).
- 使用R软件和mstate软件包进行统计分析,以确定重要的预测因素.
主要成果:
- 总体死亡率为5.6%,其中6.6%需要ICU入院,38.72%在隔离室接受治疗.
- 在护理环境中,死亡率有很大差异:3.48% (普通病房),4.56% (隔离室) 和26.6% (ICU).
- 预测ICU入院的预测因素包括年龄>60,脏疾病,心血管疾病,肺部疾病和癌症. 年龄超过60岁,糖尿病,高血压和心脏病显著增加了住院死亡风险.
结论:
- 开发的多州模型有效地预测了住院患者中的COVID-19进展情况.
- 鉴定的风险因素为临床风险分层和早期干预提供了宝贵的见解.
- 该模型支持医疗保健提供者和政策制定者优化患者管理和资源配置.
相关概念视频
01:18Steps in Outbreak Investigation
101
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
101
01:23Mechanistic Models: Compartment Models in Individual and Population Analysis
21
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
21
01:24Kaplan-Meier Approach
67
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
67
01:21Cancer Survival Analysis
313
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
313
01:20Comparing the Survival Analysis of Two or More Groups
107
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
107